Emyria’s data-backed cannabinoid treatments are changing lives
Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with unmet medical...
Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with unmet medical...
Australia’s blossoming medicinal cannabis industry is poised for a year of growth following regulatory changes made by the Therapeutic Goods...